Variations in health-related quality of life in Japanese men who underwent iodine-125 permanent brachytherapy for localized prostate cancer

Brachytherapy

Volumn 9, Issue 4, 2010, Pages 300-306

  Tanaka, Nobumichi ^a   Fujimoto, Kiyohide ^a   Asakawa, Isao ^a   Hirayama, Akihide ^a   Yoneda, Tatsuo ^a   Yoshida, Katsunori ^a   Hirao, Yoshihiko ^a   Hasegawa, Masatoshi ^a   Konishi, Noboru ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Brachytherapy; IIEF 5; Prostate cancer; Quality of life; SF 36; UCLA PCI

Indexed keywords

IODINE 125;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; DETERIORATION; HUMAN; IMPLANTATION; INTERNATIONAL INDEX OF ERECTILE FUNCTION; INTESTINE FUNCTION; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE; SCORING SYSTEM; SEXUAL FUNCTION; SHORT FORM 36; URINARY TRACT FUNCTION;

AGED; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY DOSAGE; UROGENITAL SYSTEM;

EID: 77954896991     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.07.013     Document Type: Article

References (24)

1. Fukuhara S., Bito S., Green J., et al. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998, 51:1037-1044.
2. Fukuhara S., Ware J.E., Kosinski M., et al. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol 1998, 51:1045-1053.
3. Fukuhara S., Suzukamo Y. Manual of SF-36v2 Japanese version 2004, Institute for Health Outcomes & Process Evaluation Research, Kyoto, Japan.
4. Krupski T., Petroni G.R., Bissonette E.A., et al. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology 2000, 55:736-742.
5. Brandeis J.M., Litwin M.S., Burnison C.M., et al. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 2000, 163:851-857.
6. Merrick G.S., Butler W.M., Wallner K.E., et al. Long-term urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2003, 56:454-461.
7. Downs T.M., Sadetsky N., Pasta D.J., et al. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer-Data from CaPSURE. J Urol 2003, 170:1822-1827.
8. Van Gellekom M.P., Moerland M.A., Van Vulpen M., et al. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry. Int J Radiat Oncol Biol Phys 2005, 63:772-780.
9. Feigenberg S.J., Lee W.R., Desilvio M.L., et al. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. Int J Radiat Oncol Biol Phys 2005, 62:956-964.
10. Soderdahl D.W., Davis J.W., Schellhammer P.F., et al. Prospective longitudinal comparative study of health-related quality of life in patients undergoing invasive treatments for localized prostate cancer. J Endourol 2005, 19:318-326.
11. Namiki S., Satoh T., Baba S., et al. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: A prospective longitudinal study. Urology 2006, 68:1230-1236.
12. Caffo O., Fellin G., Bolner A., et al. Prospective evaluation of quality of life after interstitial brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2006, 66:31-37.
13. Litwin M.S., Gore J.L., Kwan L., et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007, 109:2239-2247.
14. Stone N.N., Stock R.G. Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years. Urology 2007, 69:338-342.
15. Ash D., Bottomley D., Al-Qaisieh B., et al. A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancer. Radiother Oncol 2007, 84:135-139.
16. Cesaretti J.A., Kao J., Stone N.N., et al. Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: Analysis at > or = 7 years of follow-up. BJU Int 2007, 100:362-367.
17. Frank S.J., Pisters L.L., Davis J., et al. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 2007, 177:2151-2156.
18. Sanda M.G., Dunn R.L., Michalski J., et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008, 358:1250-1261.
19. Ferrer M., Suárez J.F., Guedea F., et al. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 72:421-432.
20. Sobin L.H., Ch Wittekind TNM classification of malignant tumors 2002, Wiley-Liss Inc., Hoboken, NJ. 6th ed.
21. Nag S., Beyer D., Friedland J., et al. American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999, 44:789-799.
22. Tanaka N., Asakawa I., Kondo H., et al. Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in a series of 100 patients with localized prostate cancer. Int J Urol 2009, 16:70-74.
23. Merrick G.S., Butler W.M., Dorsey A.T., et al. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 2000, 48:1069-1074.
24. Merrick G.S., Butler W.M., Galbreath R.W., et al. Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002, 52:893-902.